MRK•benzinga•
Health Canada Has Approved Merck's Keytruda (Pembrolizumab) In Combination With Pemetrexed And Platinum Chemotherapy For The First-line Treatment Of Adult Patients With Unresectable Advanced Or Metastatic Malignant Pleural Mesothelioma.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 22, 2025 by benzinga